Apogee Therapeutics is a biotechnology company established in 2022, focused on developing differentiated biologics for the treatment of several inflammatory and immunological conditions, including atopic dermatitis and chronic obstructive pulmonary disease. The company aims to create advanced antibody therapies that enhance the treatment landscape by leveraging established mechanisms of action and innovative antibody engineering. Apogee is committed to transforming the standard of care for patients facing these challenging health issues, emphasizing that individuals deserve nothing less than the best treatment options available. With a culture grounded in their C.O.R.E. values—Caring, Original, Resilient, and Egoless—Apogee encourages a collaborative, dynamic work environment where employees are empowered to contribute meaningfully and grow professionally.